Crossmark

Serum cholesterol and risk of high-grade prostate cancer: results from the REDUCE study

Crossref DOI link: https://doi.org/10.1038/s41391-017-0030-9

Published Online: 2017-12-27

Published Print: 2018-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Jamnagerwalla, Juzar

Howard, Lauren E.

Allott, Emma H.

Vidal, Adriana C.

Moreira, Daniel M.

Castro-Santamaria, Ramiro

Andriole, Gerald L.

Freeman, Michael R.

Freedland, Stephen J.
License Information

Text and Data Mining valid from 2017-12-27
More Information

Article History

Received: 14 October 2017

Accepted: 13 November 2017

First Online: 27 December 2017

Compliance with Ethical Standards

:

: The REDUCE study was funded by GlaxoSmithKline. Dr Castro-Santamaria is an employee of GlaxoSmithKline. Dr Andriole is a consultant for GlaxoSmithKline. The authors declare that they have no conflict of interest.